全球首个用于长期体重管理的GLP-1RA周制剂诺和盈(司美格鲁肽注射液)问世以来,用药物帮助减轻体重的风潮迅速席卷全球。早在2022年10月,马斯克分享了自己使用司美格鲁肽变瘦的秘诀,他的“带货”也让这款曾经潜伏在富人圈内的“减肥神药”迅速爆火。去年11月17日,诺和诺德宣布,减重版司美格鲁肽注射液正式在中国上市。上市之际,一度被哄抢,导致药企陷入产能危机。但一路高歌猛进的司美格鲁肽,不得不接受...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.